(Sharecast News) - Analysts at RBC Capital Markets cut their rating on Spire Healthcare to 'sector perform' from 'outperform' on Tuesday and lowered their price target on the stock from 300p to 250p, saying the recommended take‑private offer from a Toscafund‑led consortium effectively caps the upside for shareholders.
RBC Capital stated...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE